Frontiers
US$ 28.89
trt and glp 1 trt and glp-1 GLP-1-based therapies for type 2 diabetes: from single, dual and Best GLP-1/GIP Weight Loss Therapy
Description
N Engl J Med 387 , 205216 (2022)
Recent studies have demonstrated new anti-inflammatory properties for GLP1-R agonists
Traditional treatments such as radiotherapy, chemotherapy, and surgery have their limitations and side effects, which have led to a growing interest in natural compounds like BBR
This results in greater weight-loss outcomes
Rising Prevalence of Type 2 Diabetes Skyrocketing the GLP-1 Analogues Market Share The increasing incidence of type 2 diabetes is a major trend driving the GLP-1 analogues market
